Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

2016 update

J. K. Hicks, K. Sangkuhl, J. J. Swen, V. L. Ellingrod, D. J. Müller, K. Shimoda, J. R. Bishop, E. D. Kharasch, Todd Skaar, A. Gaedigk, H. M. Dunnenberger, T. E. Klein, K. E. Caudle, J. C. Stingl

Research output: Contribution to journalArticle

48 Citations (Scopus)
Original languageEnglish (US)
JournalClinical Pharmacology and Therapeutics
DOIs
StateAccepted/In press - 2017

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants : 2016 update. / Hicks, J. K.; Sangkuhl, K.; Swen, J. J.; Ellingrod, V. L.; Müller, D. J.; Shimoda, K.; Bishop, J. R.; Kharasch, E. D.; Skaar, Todd; Gaedigk, A.; Dunnenberger, H. M.; Klein, T. E.; Caudle, K. E.; Stingl, J. C.

In: Clinical Pharmacology and Therapeutics, 2017.

Research output: Contribution to journalArticle

Hicks, JK, Sangkuhl, K, Swen, JJ, Ellingrod, VL, Müller, DJ, Shimoda, K, Bishop, JR, Kharasch, ED, Skaar, T, Gaedigk, A, Dunnenberger, HM, Klein, TE, Caudle, KE & Stingl, JC 2017, 'Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update', Clinical Pharmacology and Therapeutics. https://doi.org/10.1002/cpt.597
Hicks, J. K. ; Sangkuhl, K. ; Swen, J. J. ; Ellingrod, V. L. ; Müller, D. J. ; Shimoda, K. ; Bishop, J. R. ; Kharasch, E. D. ; Skaar, Todd ; Gaedigk, A. ; Dunnenberger, H. M. ; Klein, T. E. ; Caudle, K. E. ; Stingl, J. C. / Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants : 2016 update. In: Clinical Pharmacology and Therapeutics. 2017.
@article{b4355280434f49f78e7fefb41f07008e,
title = "Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update",
author = "Hicks, {J. K.} and K. Sangkuhl and Swen, {J. J.} and Ellingrod, {V. L.} and M{\"u}ller, {D. J.} and K. Shimoda and Bishop, {J. R.} and Kharasch, {E. D.} and Todd Skaar and A. Gaedigk and Dunnenberger, {H. M.} and Klein, {T. E.} and Caudle, {K. E.} and Stingl, {J. C.}",
year = "2017",
doi = "10.1002/cpt.597",
language = "English (US)",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

T2 - 2016 update

AU - Hicks, J. K.

AU - Sangkuhl, K.

AU - Swen, J. J.

AU - Ellingrod, V. L.

AU - Müller, D. J.

AU - Shimoda, K.

AU - Bishop, J. R.

AU - Kharasch, E. D.

AU - Skaar, Todd

AU - Gaedigk, A.

AU - Dunnenberger, H. M.

AU - Klein, T. E.

AU - Caudle, K. E.

AU - Stingl, J. C.

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85013115073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013115073&partnerID=8YFLogxK

U2 - 10.1002/cpt.597

DO - 10.1002/cpt.597

M3 - Article

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

ER -